AMPK Cancer Research Results
AMPK, adenosine monophosphate-activated protein kinase: Click to Expand ⟱
| Source: |
| Type: |
AMPK: guardian of metabolism and mitochondrial homeostasis; Upon changes in the ATP-to-AMP ratio, AMPK is activated. (AMPK) is a key metabolic sensor that is pivotal for the maintenance of cellular energy homeostasis. It is well documented that AMPK possesses a suppressor role in the context of tumor development and progression by modulating the inflammatory and metabolic pathways.
-Activating AMPK can inhibit anabolic processes and the PI3K/Akt/mTOR pathway reducing glycolysis shifting toward Oxidative Phosphorlylation.
AMPK activators:
-metformin or AICAR
-Resveratrol: activate AMPK indirectly
-Berberine
-Quercetin: may stimulate AMPK
-EGCG: thought to activate AMPK
-Curcumin: may activate AMPK
-Ginsenosides: Some ginsenosides have been associated with AMPK activation
-Beta-Lapachone: A natural naphthoquinone compound found in the bark of Tabebuia avellanedae (also known as lapacho or taheebo). It has been observed to activate AMPK in certain models.
-Alpha-Lipoic Acid (ALA): associated with AMPK activation
|
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Thyroid, |
BCPAP |
|
|
|
- |
in-vitro, |
Thyroid, |
HTH-83 |
|
|
|
- |
in-vitro, |
Thyroid, |
CAL-62 |
|
|
|
- |
in-vitro, |
Thyroid, |
FTC-133 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCP↓, AMPK↑, mTOR↓, TumCMig↓, TumCI↓, EMT↓, E-cadherin↑, β-catenin/ZEB1↓, Vim↓, Snail↓, Twist↓, TGF-β↓, p‑SMAD2↓, TumCG↓,
NRF2↑, COX2↓, IL6↓, IL8↓, IL1↓, iNOS↓, MPO↓, TNF-α↓, VEGF↓, Hif1a↓, p‑AMPK↑,
Ferroptosis↑, ROS↑, ER Stress↑, i-Iron↓, TumAuto↑, AMPK↑, mTOR↑, P70S6K↑, Fenton↑, lipid-P↑, ROS↑, ChemoSen↑, NRF2↑, NRF2↓,
*cognitive↑, *p‑Akt↑, *p‑GSK‐3β↑, *p‑tau↓, *neuroP↑, *NF-kB↓, *AMPK↑, *NRF2↑,
*ROS↓, *MDA↓, *TNF-α↓, *IL6↓, *JAK2↓, *STAT3↓, *AMPK↑, *Sema3A/PlexinA1↑,
5LO↓, TumCCA↑, LC3B↓, PI3K↓, Akt↓, Glycolysis↓, AMPK↑, mTOR↓, Let-7↑, COX2↓, VEGF↓, CXCR4↓, MMP2↓, MMP9↓, HIF-1↓, angioG↓, TumCP↓, TumCMig↓, NF-kB↓,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
HDAC↓, AntiTum↑, TumCMig↓, AMPK↑, mTOR↑, TumAuto↑, ROS↑, miR-139-5p↑, BMI1↓, TumCI?, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, Bcl-xL↓, MMP↓, PINK1↑, PARK2↑, TumMeta↓, TumCG↓, LC3II↑, p62↓, eff↓,
Risk↓, AMPK↑, Akt↓, mTOR↓, SIRT1↑, Hif1a↓, NRF2↓, SOD↑, ROS↑, IGF-1↓, p‑Akt↓, PI3K↑, GutMicro↑, OS↑, eff↝, ROS↑, TumCCA↑, *DNArepair↑, DNAdam↑,
AMPK↑, TumCP↓, TumCMig↓, TumCI↓,
AMPK↑, TumCP↓, P21↑, mTOR↓, COX2↓,
| - |
in-vitro, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
PC, |
Bxpc-3 |
|
|
|
- |
in-vitro, |
Nor, |
hTERT-HPNE |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
AMPK↑, mTOR↑, UPR↑, ER Stress↑, selectivity↑, TumCP↓, PERK↑, ATF4↑, ATF6↑,
| - |
in-vitro, |
Lung, |
H226 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
tumCV↓, selectivity↑, TumCP↓, TumCCA↑, Apoptosis↑, mt-ROS↑, Casp3↑, Casp7↑, OCR↓, Cyt‑c↑, ATP↓, mitResp↓, AMP↑, AMPK↑,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCG↓, TumCP↓, Apoptosis↑, TumAuto↑, AMPK↑, mTOR↑, P53↑, H2O2↑, ROS↑, toxicity↝, p62↓, DR5↑, Casp8↑, PARP↑, cl‑Casp3↑,
*Inflam↓, *ROS↓, *PDGF↓, *lipid-P↓, *AMPK↑, *SIRT1↑, *AntiAg↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
GlucoseCon↓, TumCG↓, HK2↓, p‑AMPK↑, TXNIP↓, *toxicity↓,
| - |
Review, |
NA, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
NF-kB↓, P450↓, COX2↓, Hif1a↓, VEGF↓, *SIRT1↑, SIRT1↓, SIRT2↓, ChemoSen⇅, cardioP↑, *memory↑, *angioG↑, *neuroP↑, STAT3↓, CSCs↓, RadioS↑, Nestin↓, Nanog↓, TP53↑, P21↑, CXCR4↓, *BioAv↓, EMT↓, Vim↓, Slug↓, E-cadherin↑, AMPK↑, MDR1↓, DNAdam↑, TOP2↓, PTEN↑, Akt↓, Wnt↓, β-catenin/ZEB1↓, cMyc↓, MMP7↓, MALAT1↓, TCF↓, ALDH↓, CD44↓, Shh↓, IL6↓, VEGF↓, eff↑, HK2↓, ROS↑, MMP↓,
Showing Research Papers: 1 to 16 of 16
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 16
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Fenton↑, 1, Ferroptosis↑, 1, H2O2↑, 1, i-Iron↓, 1, lipid-P↑, 1, MPO↓, 1, NRF2↓, 2, NRF2↑, 2, PARK2↑, 1, ROS↑, 7, mt-ROS↑, 1, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, mitResp↓, 1, MMP↓, 2, OCR↓, 1, PINK1↑, 1,
Core Metabolism/Glycolysis ⓘ
AMP↑, 1, AMPK↑, 11, p‑AMPK↑, 2, cMyc↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, HK2↓, 2, SIRT1↓, 1, SIRT1↑, 1, SIRT2↓, 1,
Cell Death ⓘ
Akt↓, 3, p‑Akt↓, 1, Apoptosis↑, 2, BAX↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp3↑, 1, cl‑Casp3↑, 2, Casp7↑, 1, Casp8↑, 1, Cyt‑c↑, 1, DR5↑, 1, Ferroptosis↑, 1, iNOS↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Protein Folding & ER Stress ⓘ
ATF6↑, 1, ER Stress↑, 2, PERK↑, 1, UPR↑, 1,
Autophagy & Lysosomes ⓘ
LC3B↓, 1, LC3II↑, 1, p62↓, 2, TumAuto↑, 3,
DNA Damage & Repair ⓘ
DNAdam↑, 2, P53↑, 1, PARP↑, 1, cl‑PARP↑, 1, TP53↑, 1,
Cell Cycle & Senescence ⓘ
P21↑, 2, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
ALDH↓, 1, BMI1↓, 1, CD44↓, 1, CSCs↓, 1, EMT↓, 2, HDAC↓, 1, IGF-1↓, 1, Let-7↑, 1, mTOR↓, 4, mTOR↑, 4, Nanog↓, 1, Nestin↓, 1, P70S6K↑, 1, PI3K↓, 1, PI3K↑, 1, PTEN↑, 1, Shh↓, 1, STAT3↓, 1, TCF↓, 1, TOP2↓, 1, TumCG↓, 4, Wnt↓, 1,
Migration ⓘ
5LO↓, 1, E-cadherin↑, 3, MALAT1↓, 1, miR-139-5p↑, 1, MMP2↓, 1, MMP7↓, 1, MMP9↓, 1, N-cadherin↓, 1, Slug↓, 1, p‑SMAD2↓, 1, Snail↓, 2, TGF-β↓, 1, TumCI?, 1, TumCI↓, 2, TumCMig↓, 4, TumCP↓, 7, TumMeta↓, 1, Twist↓, 1, TXNIP↓, 1, Vim↓, 3, β-catenin/ZEB1↓, 2,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, ATF4↑, 1, HIF-1↓, 1, Hif1a↓, 3, VEGF↓, 4,
Immune & Inflammatory Signaling ⓘ
COX2↓, 4, CXCR4↓, 2, IL1↓, 1, IL6↓, 2, IL8↓, 1, NF-kB↓, 2, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, ChemoSen⇅, 1, eff↓, 1, eff↑, 1, eff↝, 1, MDR1↓, 1, P450↓, 1, RadioS↑, 1, selectivity↑, 2,
Clinical Biomarkers ⓘ
GutMicro↑, 1, IL6↓, 2, TP53↑, 1,
Functional Outcomes ⓘ
AntiTum↑, 1, cardioP↑, 1, OS↑, 1, Risk↓, 1, toxicity↝, 1,
Total Targets: 129
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
lipid-P↓, 1, MDA↓, 1, NRF2↑, 1, ROS↓, 2,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 3, SIRT1↑, 2,
Cell Death ⓘ
p‑Akt↑, 1,
DNA Damage & Repair ⓘ
DNArepair↑, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑GSK‐3β↑, 1, STAT3↓, 1,
Migration ⓘ
AntiAg↑, 1, PDGF↓, 1, Sema3A/PlexinA1↑, 1,
Angiogenesis & Vasculature ⓘ
angioG↑, 1,
Immune & Inflammatory Signaling ⓘ
IL6↓, 1, Inflam↓, 1, JAK2↓, 1, NF-kB↓, 1, TNF-α↓, 1,
Synaptic & Neurotransmission ⓘ
p‑tau↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1,
Clinical Biomarkers ⓘ
IL6↓, 1,
Functional Outcomes ⓘ
cognitive↑, 1, memory↑, 1, neuroP↑, 2, toxicity↓, 1,
Total Targets: 26
Scientific Paper Hit Count for: AMPK, adenosine monophosphate-activated protein kinase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:9 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page